Inhibitory effects of γ-tocotrienol on invasion and metastasis of human gastric adenocarcinoma SGC-7901 cells

Journal of Nutritional Biochemistry

Volumn 21, Issue 3, 2010, Pages 206-213

  Liu, Hui Kun ^a   Wang, Qi ^a   Li, Yang ^a   Sun, Wen Guang ^a   Liu, Jia Ren ^a,b   Yang, Yan Mei ^a   Xu, Wei Li ^a   Sun, Xiang Rong ^a   Chen, Bing Qing ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b VIRGINIA STATE UNIVERSITY   (United States)

Author keywords

Tocotrienol; Invasion; Metastasis; MMPs; SGC 7901 cells

Indexed keywords

ALPHA TOCOTRIENOL; FIBRONECTIN; GELATINASE A; GELATINASE B; MATRIGEL; MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CANCER PREVENTION; CELL MIGRATION; CELL STRAIN SGC 7901; CHEMOTAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; METASTASIS INHIBITION; METASTASIS POTENTIAL; STOMACH ADENOCARCINOMA; UPREGULATION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; CHEMOTAXIS; CHROMANS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; PROTEIN ISOFORMS; RNA, MESSENGER; STOMACH NEOPLASMS; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASES; VITAMIN E;

EID: 77049086006     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2008.11.004     Document Type: Article

References (60)

1. Kelley J.R., and Duggan J.M. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 56 (2003) 1-9
2. Katai H., Maruyama K., Sasako T., Okajima K., Kinoshita T., and Naparkov A. Mode of recurrence after gastric cancer surgery. Dig Surg 11 (1994) 99-103
3. Riboli E., and Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 78 (2003) 559S-569S
4. Gonzalez C.A., and Riboli E. Diet and cancer prevention: where we are, where we are going. Nutr Cancer 56 (2006) 225-231
5. Liu J.R., Sun X.R., Dong H.W., Sun C.H., Sun W.G., Chen B.Q., et al. beta-Ionone suppresses mammary carcinogenesis, proliferative activity and induces apoptosis in the mammary gland of the Sprague-Dawley rat. Int J Cancer 122 (2008) 2689-2698
6. Donaldson M.S. Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J 3 (2004) 19
7. Sporn M.B., and Suh N. Chemoprevention: an essential approach to controlling cancer. Nat Rev Cancer 2 (2002) 537-543
8. Shukla S., and Gupta S. Dietary agents in the chemoprevention of prostate cancer. Nutr Cancer 53 (2005) 18-32
9. Theriault A., Chao J.T., Wang Q., Gapor A., and Adeli K. Tocotrienol: a review of its therapeutic potential. Clin Biochem 32 (1999) 309-319
10. Kamal-Eldin A., and Appelqvist L.A. The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 31 (1996) 671-701
11. Heinonen M., and Piironen V. The tocopherol, tocotrienol, and vitamin E content of the average Finnish diet. Int J Vitam Nutr Res 61 (1991) 27-32
12. Nesaretnam K., Guthrie N., Chambers A.F., and Carroll K.K. Effect of tocotrienols on the growth of a human breast cancer cell line in culture. Lipids 30 (1995) 1139-1143
13. Qureshi A.A., Sami S.A., Salser W.A., and Khan F.A. Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans. Atherosclerosis 161 (2002) 199-207
14. Khanna S., Roy S., Ryu H., Bahadduri P., Swaan P.W., Ratan R.R., et al. Molecular basis of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration. J Biol Chem 278 (2003) 43508-43515
15. McIntyre B.S., Briski K.P., Gapor A., and Sylvester P.W. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc Soc Exp Biol Med 224 (2000) 292-301
16. Gysin R., Azzi A., and Visarius T. Gamma-tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins. Faseb J 16 (2002) 1952-1954
17. Shah S., Gapor A., and Sylvester P.W. Role of caspase-8 activation in mediating vitamin E-induced apoptosis in murine mammary cancer cells. Nutr Cancer 45 (2003) 236-246
18. Shun M.C., Yu W., Gapor A., Parsons R., Atkinson J., Sanders B.G., et al. Pro-apoptotic mechanisms of action of a novel vitamin E analog (alpha-TEA) and a naturally occurring form of vitamin E (delta-tocotrienol) in MDA-MB-435 human breast cancer cells. Nutr Cancer 48 (2004) 95-105
19. Shah S.J., and Sylvester P.W. Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity. Exp Biol Med (Maywood) 230 (2005) 235-241
20. Agarwal M.K., Agarwal M.L., Athar M., and Gupta S. Tocotrienol-rich fraction of palm oil activates p53, modulates Bax/Bcl2 ratio and induces apoptosis independent of cell cycle association. Cell Cycle 3 (2004) 205-211
21. Xu W.L., Liu J.R., Liu H.K., Qi G.Y., Sun X.R., Sun W.G., et al. Inhibition of proliferation and induction of apoptosis by γ-tocotrienol in human colon carcinoma HT-29 cells. Nutrition (2008) [in press]
22. Srivastava J.K., and Gupta S. Tocotrienol-rich fraction of palm oil induces cell cycle arrest and apoptosis selectively in human prostate cancer cells. Biochem Biophys Res Commun 346 (2006) 447-453
23. Sakai M., Okabe M., Tachibana H., and Yamada K. Apoptosis induction by gamma-tocotrienol in human hepatoma Hep3B cells. J Nutr Biochem 17 (2006) 672-676
24. Sun W., Wang Q., Chen B., Liu J., Liu H., and Xu W. gamma-Tocotrienol-induced apoptosis in human gastric cancer SGC-7901 cells is associated with a suppression in mitogen-activated protein kinase signalling. Br J Nutr 99 (2008) 1247-1254
25. Sun W., Xu W., Liu H., Liu R., and Chen B. γ-Tocotrienol induces mitochondria-mediated apoptosis in human gastric adenocarcinoma SGC-7901 cells. J Nutr Biochem (2008) [in press]
26. Li Z., Zhan W., Wang Z., Zhu B., He Y., Peng J., et al. Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis. Biochem Biophys Res Commun 348 (2006) 229-237
27. Li G., Selman A.A., John F.M., Ian R.H., Marc D., Charles H.S., et al. Fibronectin is chemotactic for CT 26 colon carcinoma cells: sub-lines selected for increased chemotaxis to fibronectin display decreased tumorigenicity and lung colonization. Clin Exp Metastasis 16 (1998) 683-691
28. Chen B.Q., Yang Y.M., Gao Y.H., Liu J.R., Xue Y.B., Wang X.L., et al. Inhibitory effects of c9, t11-conjugated linoleic acid on invasion of human gastric carcinoma cell line SGC-7901. World J Gastroenterol 9 (2003) 1909-1914
29. Cho H.J., Lee T.S., Park J.B., Park K.K., Choe J.Y., Sin D.I., et al. Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression. J Biochem Mol Biol 40 (2007) 1069-1076
30. Liu R.H., Liu J., and Chen B. Apples prevent mammary tumors in rats. J Agric Food Chem 53 (2005) 2341-2343
31. Buiatti E., Palli D., Bianchi S., Decarli A., Amadori D., Avellini C., et al. A case-control study of gastric cancer and diet in Italy: III. Risk patterns by histologic type. Int J Cancer 48 (1991) 369-374
32. Buiatti E., Palli D., Decarli A., Amadori D., Avellini C., Bianchi S., et al. A case-control study of gastric cancer and diet in Italy: II. Association with nutrients. Int J Cancer 45 (1990) 896-901
33. Ekstrom A.M., Serafini M., Nyren O., Hansson L.E., Ye W., and Wolk A. Dietary antioxidant intake and the risk of cardia cancer and noncardia cancer of the intestinal and diffuse types: a population-based case-control study in Sweden. Int J Cancer 87 (2000) 133-140
34. Gonzalez C.A., Riboli E., Badosa J., Batiste E., Cardona T., Pita S., et al. Nutritional factors and gastric cancer in Spain. Am J Epidemiol 139 (1994) 466-473
35. Hansson L.E., Nyren O., Bergstrom R., Wolk A., Lindgren A., Baron J., et al. Nutrients and gastric cancer risk. A population-based case-control study in Sweden. Int J Cancer 57 (1994) 638-644
36. Zheng W., Sellers T.A., Doyle T.J., Kushi L.H., Potter J.D., and Folsom A.R. Retinol, antioxidant vitamins, and cancers of the upper digestive tract in a prospective cohort study of postmenopausal women. Am J Epidemiol 142 (1995) 955-960
37. Ocke M.C., Kromhout D., Menotti A., Aravanis C., Blackburn H., Buzina R., et al. Average intake of anti-oxidant (pro)vitamins and subsequent cancer mortality in the 16 cohorts of the Seven Countries Study. Int J Cancer 61 (1995) 480-484
38. Botterweck A.A., van den Brandt P.A., and Goldbohm R.A. Vitamins, carotenoids, dietary fiber, and the risk of gastric carcinoma: results from a prospective study after 6.3 years of follow-up. Cancer 88 (2000) 737-748
39. Yap S.P., Yuen K.H., and Wong J.W. Pharmacokinetics and bioavailability of alpha-, gamma- and delta-tocotrienols under different food status. J Pharm Pharmacol 53 (2001) 67-71
40. Steeg P.S. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12 (2006) 895-904
41. Chambers A.F., Groom A.C., and MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2 (2002) 563-572
42. Christofori G. New signals from the invasive front. Nature 441 (2006) 444-450
43. Kawamura A., Miura S., Murayama T., Iwata A., Zhang B., Nishikawa H., et al. Increased expression of monocyte CD11a and intracellular adhesion molecule-1 in patients with initial atherosclerotic coronary stenosis. Circ J 68 (2004) 6-10
44. Burns S., Hardy S.J., Buddle J., Yong K.L., Jones G.E., and Thrasher A.J. Maturation of DC is associated with changes in motile characteristics and adherence. Cell Motil Cytoskeleton 57 (2004) 118-132
45. Ponta H., Hofmann M., and Herrlich P. Recent advances in the genetics of metastasis. Eur J Cancer 30A (1994) 1995-2001
46. Giancotti F.G., and Ruoslahti E. Integrin signaling. Science 285 (1999) 1028-1032
47. Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2 (2002) 161-174
48. Matsunaga Y, Koda M, and Murawaki Y. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue. Res Commun Mol Pathol Pharmacol 2004; 115-116: 143-150
49. Soini Y., Satta J., Maatta M., and Autio-Harmainen H. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart. J Pathol 194 (2001) 225-231
50. Yasuhito K., Ysuyoshi Y., and Mutsuo I. Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells. Oncol Rep 9 (2002) 565-569
51. Liotta L.A., Steeg P.S., and Stetler-Stevenson W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64 (1991) 327-336
52. Iwasaki M., Nishikawa A., Fujimoto T., Akutagawa N., Manase K., Endo T., et al. Anti-invasive effect of MMI-166, a new selective matrix metalloproteinase inhibitor, in cervical carcinoma cell lines. Gynecol Oncol 85 (2002) 103-107
53. Tanimura S., Kadomoto R., Tanaka T., Zhang Y.J., Kouno I., and Kohno M. Suppression of tumor cell invasiveness by hydrolyzable tannins (plant polyphenols) via the inhibition of matrix metalloproteinase-2/-9 activity. Biochem Biophys Res Commun 330 (2005) 1306-1313
54. Jiang Y., Goldberg I.D., and Shi Y.E. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 21 (2002) 2245-2252
55. Liu J.R., Yang B.F., Chen B.Q., Yang Y.M., Dong H.W., and Song Y.Q. Inhibition of beta-ionone on SGC-7901 cell proliferation and upregulation of metalloproteinases-1 and -2 expression. World J Gastroenterol 10 (2004) 167-171
56. Stetler-Stevenson W.G., Brown P.D., Onisto M., Levy A.T., and Liotta L.A. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 265 (1990) 13933-13938
57. Soufir N., Daya-Grosjean L., de La Salmoniere P., Moles J.P., Dubertret L., Sarasin A., et al. Association between INK4a-ARF and p53 mutations in skin carcinomas of xeroderma pigmentosum patients. J Natl Cancer Inst 92 (2000) 1841-1847
58. Berney C.R., Fisher R.J., Yang J., Russell P.J., and Crowe P.J. Genomic alterations (LOH, MI) on chromosome 17q21-23 and prognosis of sporadic colorectal cancer. Int J Cancer 89 (2000) 1-7
59. Chow N.H., Liu H.S., and Chan S.H. The role of nm23-H1 in the progression of transitional cell bladder cancer. Clin Cancer Res 6 (2000) 3595-3599
60. Leone A., Flatow U., VanHoutte K., and Steeg P.S. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene 8 (1993) 2325-2333